Related Experiment Video

Updated: Aug 13, 2026

Biochemical Titration of Glycogen In vitro
07:16

Biochemical Titration of Glycogen In vitro

Published on: November 24, 2013

Glycogen storage disease (type I) presenting in the neonatal period

B R Hufton, B A Wharton

    Archives of Disease in Childhood
    |April 1, 1982
    PubMed

    Insights

    Early diagnosis and treatment are crucial for infants with type I glycogen storage disease (GSD I). Prompt intervention ensures infants thrive, highlighting the importance of recognizing subtle symptoms for timely GSD I management.

    Area of Science:

    • Biochemistry
    • Pediatrics
    • Genetics

    Background:

    • Type I glycogen storage disease (GSD I) is a rare inherited metabolic disorder.
    • It affects glucose metabolism, leading to hypoglycemia and other complications in infants.

    Observation:

    • This study describes four Asian infants with GSD I.
    • Diagnostic challenges were noted, including easily controlled symptoms in one case and diagnosis via incidental hyperlipidemia in another.
    • Delayed diagnosis occurred in one infant due to mild initial presentation.

    Findings:

    • Three infants who received early treatment are thriving.
    • Liver histology in one treated infant appeared normal, initially causing diagnostic uncertainty.
    • The study highlights variability in clinical presentation and diagnostic pathways for GSD I.

    Implications:

    • Early recognition and intervention are critical for favorable outcomes in GSD I.
    • Increased awareness of diverse clinical presentations is needed for prompt diagnosis.
    • Effective management can lead to normal growth and development, potentially with normalized biochemical markers.

    More Related Videos

    Detecting Glycogen in Peripheral Blood Mononuclear Cells with Periodic Acid Schiff Staining09:42

    Detecting Glycogen in Peripheral Blood Mononuclear Cells with Periodic Acid Schiff Staining

    Published on: December 23, 2014

    The Extraction of Liver Glycogen Molecules for Glycogen Structure Determination04:50

    The Extraction of Liver Glycogen Molecules for Glycogen Structure Determination

    Published on: February 8, 2022

    Related Concept Videos

    Glucose Transporters01:27

    Glucose Transporters

    Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
    Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
    Inborn Errors of Metabolism01:20

    Inborn Errors of Metabolism

    Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
    Pathophysiology of Diabetes01:20

    Pathophysiology of Diabetes

    Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
    Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
    Type I Diabetes I: Introduction01:12

    Type I Diabetes I: Introduction

    Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
    Type I Diabetes III: Clinical Manifestations01:19

    Type I Diabetes III: Clinical Manifestations

    Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...